Uptravi Tablet, Film Coated
Product Images NDC 66215-910
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Uptravi (NDC 66215-910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actelion Pharmaceuticals Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Uptravi 02)
Chemical Structure (Uptravi 03)
Figure 1 (Uptravi 04)
Figure 2 (Uptravi 05)
Figure 3 (Uptravi 06)
Figure 4a (Uptravi 07)
Figure 4b (Uptravi 08)
Figure 4c (Uptravi 09)
Figure 5 (Uptravi 10)
Principal Display Panel (200 mcg Tablet Bottle Carton)
Principal Display Panel (400 mcg Tablet Bottle Carton)
Principal Display Panel (600 mcg Tablet Bottle Carton)
Principal Display Panel (800 mcg Tablet Bottle Carton)
Principal Display Panel (1000 mcg Tablet Bottle Carton)
Principal Display Panel (1200 mcg Tablet Bottle Carton)
Principal Display Panel (1400 mcg Tablet Bottle Carton)
Principal Display Panel (1600 mcg Tablet Bottle Carton)
Principal Display Panel (Kit Carton)
Principal Display Panel (1,800 mcg Vial Carton)
Principal Display Panel (100 mcg Tablet Bottle Carton)
Principal Display Panel (150 mcg Tablet Bottle Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.